肥胖对重型2019冠状病毒病肺炎管理的影响
该回顾性病例对照研究在34张床的ICU中,比较首批44例COVID-19相关ARDS患者与COVID-19危机前收治的39例连续ARDS历史对照组。COVID-19组肥胖更常见(73% vs 28%,p<0.001),尽管入院疾病严重度和低氧程度相同,COVID-19组高流量鼻导管氧疗失败更多(100% vs 45%,p=0.002)、插管更多(100% vs 56%,p<0.001)、肌松更多(77% vs 14%,p<0.001)、所需PEEP更高(15 vs 8 cm H2O,p<0.001)、俯卧位更多(75% vs 27%,p<0.001)、透析更多(36% vs 8%,p=0.003)、血管活性药支持更多(82% vs 56%,p=0.001)、脱机延长更多(64% vs 26%,p<0.01)、气管切开更多(40.9% vs 9%,p=0.01)。但通过增加每例患者人力进行俯卧位等强化管理(6[5-7] vs 5[4-5]人,p<0.001),两组ICU生存率相同(77% vs 74%,p=0.23)。
要点
- COVID-19相关ARDS患者中肥胖是最常见合并症(32/44,73% vs 对照组11/39,28%,p<0.001)。
- 尽管入院疾病严重度和低氧程度相同,COVID-19组高流量鼻导管氧疗尝试全部失败(16/16,100% vs 5/11,45%,p=0.002),全部插管(44/44,100% vs 22/39,56%,p<0.001)。
- COVID-19组所需PEEP更高(15 vs 8 cm H2O,p<0.001),俯卧位更多(33/44,75% vs 6/39,27%,p<0.001)。
- COVID-19组更多需要透析(16/44,36% vs 3/39,8%,p=0.003)和血管活性药(36/44,82% vs 22/39,56%,p=0.001)。
- 强化管理增加每例患者人力用于俯卧位(6[5-7] vs 5[4-5]人,p<0.001),两组ICU生存率相同(34/44,77% vs 29/39,74%,p=0.23)。
适用人群与场景
- 因重型严重急性呼吸综合征冠状病毒病2019肺炎导致急性呼吸窘迫综合征而收入ICU的危重患者。
- 研究纳入首批44例COVID-19 ARDS患者,对照为COVID-19危机前收治的39例连续ARDS患者。
处置流程与药物剂量
- COVID-19患者需要更高的呼气末正压(15 vs 对照组8 cm H2O,p<0.001)。
- COVID-19患者更多接受俯卧位通气(33/44,75% vs 6/39,27%,p<0.001),俯卧位时每例患者需要更多人力(6[5-7] vs 5[4-5]人,p<0.001)。
- COVID-19患者更多接受肌松(34/44,77% vs 3/39,14%,p<0.001)、透析(16/44,36% vs 3/39,8%,p=0.003)和血管活性药支持(36/44,82% vs 22/39,56%,p=0.001)。
- COVID-19患者脱机延长更多(28/44,64% vs 10/39,26%,p<0.01),气管切开更多(18/44,40.9% vs 2/39,9%,p=0.01)。
研究设计与关键结果
- 回顾性病例对照研究,在34张床的ICU中比较44例COVID-19 ARDS患者与39例历史ARDS对照。
- COVID-19组肥胖更常见(32/44,73% vs 11/39,28%,p<0.001)。
- 尽管入院疾病严重度和低氧程度相同,COVID-19组高流量鼻导管氧疗失败更多(16/16,100% vs 5/11,45%,p=0.002)、插管更多(44/44,100% vs 22/39,56%,p<0.001)、肌松更多(34/44,77% vs 3/39,14%,p<0.001)。
- COVID-19组所需PEEP更高(15 vs 8 cm H2O,p<0.001),俯卧位更多(33/44,75% vs 6/39,27%,p<0.001),透析更多(16/44,36% vs 3/39,8%,p=0.003),血管活性药更多(36/44,82% vs 22/39,56%,p=0.001),脱机延长更多(28/44,64% vs 10/39,26%,p<0.01),气管切开更多(18/44,40.9% vs 2/39,9%,p=0.01)。
- ICU生存率两组无显著差异(34/44,77% vs 29/39,74%,p=0.23)。
证据类型、等级与局限
- 证据类型:回顾性病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于因重型COVID-19肺炎导致ARDS的肥胖患者,高流量鼻导管氧疗可能失败,需准备更早插管和有创通气。
- 此类患者可能需要更高的PEEP、更多俯卧位通气和肌松,且俯卧位需要更多人力(每例6[5-7]人)。
- 尽管病情更重、资源消耗更大,强化管理下ICU生存率与历史ARDS对照组相同(77% vs 74%,p=0.23)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate patients' characteristics, management, and outcomes in the critically ill population admitted to the ICU for severe acute respiratory syndrome coronavirus disease 2019 pneumonia causing an acute respiratory distress syndrome.
DESIGN: Retrospective case-control study.
SETTING: A 34-bed ICU of a tertiary hospital.
PATIENTS: The first 44 coronavirus disease 2019 acute respiratory distress syndrome patients were compared with a historical control group of 39 consecutive acute respiratory distress syndrome patients admitted to the ICU just before the coronavirus disease 2019 crisis.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Obesity was the most frequent comorbidity exhibited by coronavirus disease 2019 patients (n = 32, 73% vs n = 11, 28% in controls; p < 0.001). Despite the same severity of illness and level of hypoxemia at admission, coronavirus disease 2019 patients failed more high flow oxygen via nasal cannula challenges (n = 16, 100% vs n = 5, 45% in controls; p = 0.002), were more often intubated (n = 44, 100% vs n = 22, 56% in controls; p < 0.001) and paralyzed (n = 34, 77% vs n = 3, 14% in controls; p < 0.001), required higher level of positive end-expiratory pressure (15 vs 8 cm H2O in controls; p < 0.001), more prone positioning (n = 33, 75% vs n = 6, 27% in controls; p < 0.001), more dialysis (n = 16, 36% vs n = 3, 8% in controls; p = 0.003), more hemodynamic support by vasopressors (n = 36, 82% vs n = 22, 56% in controls; p = 0.001), and had more often a prolonged weaning from mechanical ventilation (n = 28, 64% vs n = 10, 26% in controls; p < 0.01) resulting in a more frequent resort to tracheostomy (n = 18, 40.9% vs n = 2, 9% in controls; p = 0.01). However, an intensive management requiring more staff per patient for positioning coronavirus disease 2019 subjects (6 [5-7] vs 5 [4-5] in controls; p < 0.001) yielded the same ICU survival rate in the two groups (n = 34, 77% vs n = 29, 74% in controls; p = 0.23).
CONCLUSIONS: In its most severe form, coronavirus disease 2019 pneumonia striked preferentially the vulnerable obese population, evolved toward a multiple organ failure, required prolonged mechanical ventilatory support, and resulted in a high workload for the caregivers.
参考来源
- Lemyze M, Courageux N, Maladobry T, et al. Implications of Obesity for the Management of Severe Coronavirus Disease 2019 Pneumonia. Crit Care Med. 2020. PMID: 32452889. doi:10.1097/CCM.0000000000004455
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。